CA Patent

CA3267788A1 — Combination of macrocyclic cftr modulators with cftr correctors and / or cftr potentiators

Assigned to Idorsia Pharmaceuticals Ltd · Expires 2024-03-21 · 2y expired

What this patent protects

Patent listed against Kalydeco.

Drugs covered by this patent

Patent Metadata

Patent number
CA3267788A1
Jurisdiction
CA
Classification
—
Expires
2024-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Idorsia Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.